Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,924 | -20,141 | -11,401 | -6,387 | 1,840 |
| Depreciation Amortization | 74 | 112 | 47 | 38 | 23 |
| Accounts receivable | N/A | N/A | N/A | N/A | -4,000 |
| Accounts payable and accrued liabilities | 211 | 242 | -89 | -87 | 200 |
| Other Working Capital | -857 | 1,472 | 470 | 608 | -5,028 |
| Other Operating Activity | 5,198 | -4,521 | -4,593 | -3,050 | 250 |
| Operating Cash Flow | $-9,298 | $-22,836 | $-15,566 | $-8,878 | $-6,715 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 19 | 20 | -16 | -12 |
| Purchase Of Investment | -8,691 | -52,082 | -34,244 | -28,168 | -16,529 |
| Sale Of Investment | 13,928 | 56,241 | 43,404 | 26,356 | 16,856 |
| Investing Cash Flow | $5,237 | $4,178 | $9,180 | $-1,828 | $315 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 9,625 | N/A | N/A | N/A |
| Common Stock Issued | 32 | 4,121 | 4,057 | 4,057 | 2,091 |
| Financing Cash Flow | $32 | $13,746 | $4,057 | $4,057 | $2,091 |
| Beginning Cash Position | 9,311 | 14,223 | 14,223 | 14,223 | 14,223 |
| End Cash Position | 5,282 | 9,311 | 11,894 | 7,574 | 9,914 |
| Net Cash Flow | $-4,029 | $-4,912 | $-2,329 | $-6,649 | $-4,309 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,298 | -22,836 | -15,566 | -8,878 | -6,715 |
| Capital Expenditure | N/A | -15 | -15 | -16 | -12 |
| Free Cash Flow | -9,298 | -22,851 | -15,581 | -8,894 | -6,727 |